Joseph Moore
University of California, Davis
4 Papers
31 Citations
Joseph Moore is an academic researcher from University of California, Davis. The author has contributed to research in topics: Immunogenicity & Antibody. The author has an hindex of 3, co-authored 4 publications. Previous affiliations of Joseph Moore include California National Primate Research Center.
Chat about Author
Papers
Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.
Koen K. A. Van Rompay,Lucie Durand-Gasselin,Laurie L. Brignolo,Adrian S. Ray,Kristina Abel,Tomas Cihlar,Abigail Spinner,Christopher Jerome,Joseph Moore,Brian P. Kearney,Marta L. Marthas,Hans Reiser,Norbert Bischofberger +12 more
TL;DR: Findings illustrate the safety and sustained benefits of prolonged TFV-containing regimens throughout development from infancy to adulthood, including pregnancy.
125
Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.
Koen K. A. Van Rompay,Kristina Abel,Kristina Abel,Patricia L. Earl,Pamela A. Kozlowski,Juliet L. Easlick,Joseph Moore,Linda Buonocore-Buzzelli,Kimberli A. Schmidt,Robert L. Wilson,Ian D. Simon,Bernard Moss,Nina F. Rose,John K. Rose,Marta L. Marthas +14 more
TL;DR: The safety and immunogenicity of the VSV-SIVgpe+MVA-Siv immunization regimen described in this report provide the scientific incentive to explore the efficacy of this vaccine regimen against virulent SIV exposure in the infant macaque model.
31
VSV/MVA vaccine rapidly elicits SIV antibodies and local and systemic SIV T cell responses in macaque neonates but does not prevent SIV dissemination after oral challenge
Kristina Abel,Koen K. A. Van Rompay,Juliet Eastlick,Joseph Moore,Mathieu Lemieux,Kimberly Schmidt,Patricia L. Earl,Linda Buonocore-Buzzelli,Bernard Moss,Nina F. Rose,John K. Rose,Michael B. McChesney,Pamela A. Kozlowski,Marta L. Marthas +13 more
TL;DR: VSV/MVA vaccine rapidly elicits SIV antibodies and local and systemic SIV T cell responses in macaque neonates but does not prevent SIV dissemination after oral challenge.
1
Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome-DNA complexes in a rhesus macaque pilot study.
Jeff Fairman,Joseph Moore,Mathieu Lemieux,Koen K. A. Van Rompay,Yongzhi Geng,John Warner,Kristina Abel +6 more
TL;DR: Rhesus macaques immunized in the presence of CLDC developed stronger SIV-specific T and B cell responses compared to animals immunized without CLDC, which resulted in better memory responses after an in-vivo boost of the animals several months later with whole AT-2 inactivated SIVmac239.